This role of CRIF1 might possibly exert through its interaction with CDK2 that consequently increased the levels of negative regulators, such as p15, p16, p21, p27 and p53, and ultimately lead to cell cycle arrest in the leukemia cells. Here, TP53 is linked to leukemia.